Variable asialoglycoprotein receptor 1 expression in liver disease: Implications for therapeutic intervention
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Variable asialoglycoprotein receptor 1 expression in liver disease: Implications for therapeutic intervention
Authors
Keywords
-
Journal
HEPATOLOGY RESEARCH
Volume 46, Issue 7, Pages 686-696
Publisher
Wiley
Online
2015-10-01
DOI
10.1111/hepr.12599
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Image-guided drug delivery: preclinical applications and clinical translation
- (2015) Tarun Ojha et al. Expert Opinion on Drug Delivery
- Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
- (2015) Andreas Wicki et al. JOURNAL OF CONTROLLED RELEASE
- Going beyond the liver: Progress and challenges of targeted delivery of siRNA therapeutics
- (2015) Cornelia Lorenzer et al. JOURNAL OF CONTROLLED RELEASE
- Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs
- (2014) Adam Castaño et al. HEART FAILURE REVIEWS
- Development of a liver-targeted siRNA delivery platform with a broad therapeutic window utilizing biodegradable polypeptide-based polymer conjugates
- (2014) Stephanie E. Barrett et al. JOURNAL OF CONTROLLED RELEASE
- Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
- (2014) Jayaprakash K. Nair et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Targeted delivery of antisense oligonucleotides to hepatocytes using triantennaryN-acetyl galactosamine improves potency 10-fold in mice
- (2014) Thazha P. Prakash et al. NUCLEIC ACIDS RESEARCH
- Active radar guides missile to its target: receptor-based targeted treatment of hepatocellular carcinoma by nanoparticulate systems
- (2014) Jing-Jun Yan et al. TUMOR BIOLOGY
- Galactose-Decorated Reduction-Sensitive Degradable Chimaeric Polymersomes as a Multifunctional Nanocarrier To Efficiently Chaperone Apoptotic Proteins into Hepatoma Cells
- (2013) Xiaoyan Wang et al. BIOMACROMOLECULES
- Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients
- (2013) Luca Quagliata et al. HEPATOLOGY
- Lactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma
- (2013) Mengzi Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Hepatocyte targeting using pegylated asialofetuin-conjugated liposomes
- (2013) Pascal Detampel et al. JOURNAL OF DRUG TARGETING
- Liver as a target for oligonucleotide therapeutics
- (2013) Alfica Sehgal et al. JOURNAL OF HEPATOLOGY
- Expression of Asialoglycoprotein Receptor 1 in Human Hepatocellular Carcinoma
- (2013) Bin Shi et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Mouse models for liver cancer
- (2013) Latifa Bakiri et al. Molecular Oncology
- Hepatocyte-targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus Infection
- (2013) Christine I Wooddell et al. MOLECULAR THERAPY
- Delivery materials for siRNA therapeutics
- (2013) Rosemary Kanasty et al. NATURE MATERIALS
- Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: Lost and found
- (2012) Eirini I. Rigopoulou et al. AUTOIMMUNITY REVIEWS
- Drug targeting to the diseased liver
- (2012) Klaas Poelstra et al. JOURNAL OF CONTROLLED RELEASE
- Inhibition of Hepatitis B Virus and Induction of Hepatoma Cell Apoptosis by ASGPR-Directed Delivery of shRNAs
- (2012) Jingwei Ma et al. PLoS One
- Nanotechnology for therapy and imaging of liver diseases
- (2011) L. Harivardhan Reddy et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma: insight from animal models
- (2011) Yan Li et al. Nature Reviews Gastroenterology & Hepatology
- Hepatocellular carcinoma: a global view
- (2010) Ju Dong Yang et al. Nature Reviews Gastroenterology & Hepatology
- Models of Hepatocellular Carcinoma and Biomarker Strategy
- (2010) Cedo M. Bagi et al. Cancers
- Sorafenib
- (2009) Gillian M. Keating et al. DRUGS
- An Internalizing Antibody Specific for the Human Asialoglycoprotein Receptor
- (2009) Alla Trahtenherts et al. HYBRIDOMA
- Experimental mouse models for hepatocellular carcinoma research
- (2009) Femke Heindryckx et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells
- (2009) Haluk Yuzugullu et al. Molecular Cancer
- Glypican 3 Expression in Human Nonneoplastic, Preneoplastic, and Neoplastic Tissues
- (2008) Daniel Baumhoer et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Trivalent, Gal/GalNAc-containing ligands designed for the asialoglycoprotein receptor
- (2008) Oleg Khorev et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Asialoglycoprotein receptor-targeted superparamagnetic iron oxide nanoparticles
- (2008) Guifang Huang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The Asialoglycoprotein Receptor Regulates Levels of Plasma Glycoproteins Terminating with Sialic Acid α2,6-Galactose
- (2008) Lindsay M. Steirer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nanoparticles for drug delivery: The need for precision in reporting particle size parameters
- (2007) Marie Gaumet et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started